114 related articles for article (PubMed ID: 9703274)
1. Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo.
Barker KT; Crompton MR
Br J Cancer; 1998 Aug; 78(3):296-300. PubMed ID: 9703274
[TBL] [Abstract][Full Text] [Related]
2. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line.
Huang Y; Saez R; Chao L; Santos E; Aaronson SA; Chan AM
Oncogene; 1995 Oct; 11(7):1255-60. PubMed ID: 7478545
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers.
Clark GJ; Kinch MS; Gilmer TM; Burridge K; Der CJ
Oncogene; 1996 Jan; 12(1):169-76. PubMed ID: 8552388
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
Rokavec M; Schroth W; Amaral SM; Fritz P; Antoniadou L; Glavac D; Simon W; Schwab M; Eichelbaum M; Brauch H
Cancer Res; 2008 Dec; 68(23):9799-808. PubMed ID: 19047159
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
Mandai M; Konishi I; Komatsu T; Mori T; Arao S; Nomura H; Kanda Y; Hiai H; Fukumoto M
Br J Cancer; 1995 Sep; 72(3):691-5. PubMed ID: 7669582
[TBL] [Abstract][Full Text] [Related]
7. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.
Chan AM; Miki T; Meyers KA; Aaronson SA
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7558-62. PubMed ID: 8052619
[TBL] [Abstract][Full Text] [Related]
8. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer.
Rochlitz CF; Scott GK; Dodson JM; Liu E; Dollbaum C; Smith HS; Benz CC
Cancer Res; 1989 Jan; 49(2):357-60. PubMed ID: 2642738
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells.
Rosário M; Paterson HF; Marshall CJ
EMBO J; 1999 Mar; 18(5):1270-9. PubMed ID: 10064593
[TBL] [Abstract][Full Text] [Related]
10. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
Rosário M; Paterson HF; Marshall CJ
Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
[TBL] [Abstract][Full Text] [Related]
12. Analysis of oncogene alterations in human endometrial carcinoma: prevalence of ras mutations.
Boyd J; Risinger JI
Mol Carcinog; 1991; 4(3):189-95. PubMed ID: 2064724
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of activating ras mutations in morphologically characterized thyroid nodules.
Ezzat S; Zheng L; Kolenda J; Safarian A; Freeman JL; Asa SL
Thyroid; 1996 Oct; 6(5):409-16. PubMed ID: 8936664
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of EP300 in colon, breast and ovarian carcinomas.
Bryan EJ; Jokubaitis VJ; Chamberlain NL; Baxter SW; Dawson E; Choong DY; Campbell IG
Int J Cancer; 2002 Nov; 102(2):137-41. PubMed ID: 12385008
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
16. Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.
Huang Y; Rangwala F; Fulkerson PC; Ling B; Reed E; Cox AD; Kamholz J; Ratner N
Oncogene; 2004 Jan; 23(2):368-78. PubMed ID: 14724565
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
Wegman P; Ahlin C; Sorbe B
Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutations in endometrial carcinomas with microsatellite instability.
Lagarda H; Catasus L; Arguelles R; Matias-Guiu X; Prat J
J Pathol; 2001 Feb; 193(2):193-9. PubMed ID: 11180166
[TBL] [Abstract][Full Text] [Related]
19. ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.
Johnstone CN; Castellví-Bel S; Chang LM; Bessa X; Nakagawa H; Harada H; Sung RK; Piqué JM; Castells A; Rustgi AK
Gene; 2004 Jul; 336(1):59-71. PubMed ID: 15225876
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection of K-ras gene mutations in canine lung cancer using single-strand conformational polymorphism analysis.
Griffey SM; Kraegel SA; Madewell BR
Carcinogenesis; 1998 Jun; 19(6):959-63. PubMed ID: 9667731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
